Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Crossover study with cisplatin or carboplatin in advanced ovarian cancer.
Repetto L, Chiara S, Mammoliti S, Guido T, Bruzzone M, Secondo V, Donadio G, Odicino F, Ragni N, Conte PF, et al. Repetto L, et al. Among authors: mammoliti s. Gynecol Oncol. 1990 Nov;39(2):146-9. doi: 10.1016/0090-8258(90)90422-h. Gynecol Oncol. 1990. PMID: 2227588 Clinical Trial.
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.
Conte PF, Bruzzone M, Carnino F, Gadducci A, Algeri R, Bellini A, Boccardo F, Brunetti I, Catsafados E, Chiara S, Foglia G, Gallo L, Iskra L, Mammoliti S, Parodi G, Ragni N, Rosso R, Rugiati S, Rubagotti A. Conte PF, et al. Among authors: mammoliti s. J Clin Oncol. 1996 Feb;14(2):351-6. doi: 10.1200/JCO.1996.14.2.351. J Clin Oncol. 1996. PMID: 8636743 Clinical Trial.
Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study.
Miglietta L, Amoroso D, Bruzzone M, Granetto C, Catsafados E, Mammoliti S, Guarneri D, Pedulla F, Foglia G, Ragni N, Martini MC, Brema F, Addamo G, Moraglio L, Pastorino G, Boccardo F. Miglietta L, et al. Among authors: mammoliti s. Oncology. 1997 Mar-Apr;54(2):102-7. doi: 10.1159/000227671. Oncology. 1997. PMID: 9075779 Clinical Trial.
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest.
Bruzzone M, Rubagotti A, Gadducci A, Catsafados E, Foglia G, Brunetti I, Giannessi PG, Carnino F, Iskra L, Rosso R, Martoni A, Pannuti F, De Lisi V, Maltoni R, Ridolfi R, Mammoliti S, Gallo L, Boccardo F, Ragni N, Conte PF. Bruzzone M, et al. Among authors: mammoliti s. Gynecol Oncol. 1997 Jun;65(3):499-505. doi: 10.1006/gyno.1997.4689. Gynecol Oncol. 1997. PMID: 9190982 Clinical Trial.
65 results